Vanguard Group Inc Cytom X Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CTMX
# of Institutions
72Shares Held
49.4MCall Options Held
112KPut Options Held
8.3K-
Tang Capital Management LLC San Diego, CA7.81MShares$7.19 Million0.79% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.81 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X04.81MShares$4.42 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.1MShares$2.85 Million0.01% of portfolio
-
Prosight Management, LP Dallas, TX3.02MShares$2.78 Million0.96% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $60.7M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...